Diabetes type 2 is a chronic condition. In addition to regular medical examinations, it necessitates the administration of drugs to help control blood sugar levels.
A diabetes drug will protect against dementia
Dr. Eosu Kim’s research at Yonsei University in South Korea has demonstrated that dementia can be prevented from progressing over time with prompt intervention.
People with ischemic heart disease or those who had previously experienced a stroke benefited from the type 2 diabetes medication pioglitazone. These patients had a 43 and 54% lower chance of getting dementia, respectively.
In participants taking the medication for two years and for four years, the decline in dementia cases was 22% and 37%, respectively. Up to 91,218 South Koreans whose health was tracked for ten years provided data for the study. Of them, 3,467 were given pioglitazone.
Lower risk of stroke
Researchers found that pioglitazone-taking study participants had a lower risk of stroke. According to the study’s lead author, the information gathered could be a useful tool for creating dementia prevention in the future, which would be “a game changer.”
There is no connection between pioglitazone and preventing dementia, according to earlier studies in individuals with dementia or at risk for cognitive decline who did not have diabetes.
